EP1392346A4 - COMPOUNDS AND METHODS FOR INCREASING TISSUE ELASTICITY - Google Patents

COMPOUNDS AND METHODS FOR INCREASING TISSUE ELASTICITY

Info

Publication number
EP1392346A4
EP1392346A4 EP01941684A EP01941684A EP1392346A4 EP 1392346 A4 EP1392346 A4 EP 1392346A4 EP 01941684 A EP01941684 A EP 01941684A EP 01941684 A EP01941684 A EP 01941684A EP 1392346 A4 EP1392346 A4 EP 1392346A4
Authority
EP
European Patent Office
Prior art keywords
tissue
composition
enhancing elasticity
enhancing
elasticity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP01941684A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1392346A2 (en
Inventor
Thomas F Mitts
Lawrence B Sandberg
Felipe Jimenez Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Connective Tissue Imagineering LLC
Original Assignee
Connective Tissue Imagineering LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/584,001 external-priority patent/US6506731B1/en
Priority claimed from US09/580,893 external-priority patent/US6794362B1/en
Priority claimed from US09/580,110 external-priority patent/US6809075B1/en
Priority claimed from US09/580,156 external-priority patent/US6962904B1/en
Application filed by Connective Tissue Imagineering LLC filed Critical Connective Tissue Imagineering LLC
Publication of EP1392346A2 publication Critical patent/EP1392346A2/en
Publication of EP1392346A4 publication Critical patent/EP1392346A4/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP01941684A 2000-05-30 2001-05-30 COMPOUNDS AND METHODS FOR INCREASING TISSUE ELASTICITY Ceased EP1392346A4 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US580156 2000-05-30
US09/584,001 US6506731B1 (en) 1998-03-13 2000-05-30 Elastin peptide analogs and methods of using same
US584001 2000-05-30
US580893 2000-05-30
US09/580,893 US6794362B1 (en) 2000-05-30 2000-05-30 Asparagine containing elastin peptide analogs
US09/580,110 US6809075B1 (en) 2000-05-30 2000-05-30 Elastin peptide analogs and uses of same incombination with skin enhancing agents
US580110 2000-05-30
US09/580,156 US6962904B1 (en) 1998-03-13 2000-05-30 Elastin peptide analogs and uses thereof
PCT/US2001/017384 WO2001091700A2 (en) 2000-05-30 2001-05-30 Composition and method for enhancing elasticity of tissue

Publications (2)

Publication Number Publication Date
EP1392346A2 EP1392346A2 (en) 2004-03-03
EP1392346A4 true EP1392346A4 (en) 2006-10-25

Family

ID=27504943

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01941684A Ceased EP1392346A4 (en) 2000-05-30 2001-05-30 COMPOUNDS AND METHODS FOR INCREASING TISSUE ELASTICITY

Country Status (7)

Country Link
EP (1) EP1392346A4 (no)
AU (2) AU2001275018B2 (no)
CA (1) CA2415225A1 (no)
IL (1) IL153687A0 (no)
NO (1) NO20030454L (no)
NZ (1) NZ523403A (no)
WO (1) WO2001091700A2 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2827170B1 (fr) * 2001-07-13 2004-07-16 Soc Extraction Principes Actif Utilisation de peptides pour augmenter l'adhesion cellulaire
WO2003030860A1 (en) * 2001-10-05 2003-04-17 Procyte Corporation Skin care compositions containing peptide copper complexes and retinol, retinol derivatives, or a mixture thereof
KR20050033510A (ko) * 2001-10-05 2005-04-12 프로사이트 코포레이션 피부의 색소 과다 침착의 치료방법
US20040138103A1 (en) * 2002-11-07 2004-07-15 Procyte Corporation Compositions containing peptide copper complexes and metalloproteinase inhibitors and methods related thereto
DE10260928A1 (de) * 2002-12-20 2004-07-08 Henkel Kgaa Verfahren zur Bestimmung von Markern humaner Gesichtshaut
US6927205B2 (en) 2003-04-28 2005-08-09 Procyte Corporation Compositions and methods for treatment of psoriasis
FR2854897B1 (fr) * 2003-05-12 2007-05-04 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane.
EP1765280A1 (en) * 2004-06-28 2007-03-28 Procyte Corporation Methods and compositions for preventing and treating hyperpigmentation of skin
CA2652388A1 (en) 2006-05-15 2007-11-22 Valio Ltd New use of therapeutically useful peptides
WO2008100789A2 (en) 2007-02-16 2008-08-21 Benaroya Research Institute At Virginia Mason Compositions and methods for altering elastogenesis
CN103458911B (zh) 2011-02-11 2016-02-24 密歇根大学董事会 肽组合物和用于治疗患者的方法
MX2013010977A (es) 2011-03-31 2013-10-30 Procter & Gamble Sistema, modelos y metodos para identificar y evaluar agentes dermoactivos eficaces para tratar la caspa/dermatitis seborreica.
JP2015527630A (ja) 2012-06-06 2015-09-17 ザ プロクター アンド ギャンブルカンパニー ヘア／頭皮ケア組成物向け化粧剤の同定システム及び方法
FR3116273B1 (fr) * 2020-11-17 2023-10-27 Sederma Sa Tétrapeptides, compositions les comprenant et leur utilisation cosmétique
KR102484277B1 (ko) * 2021-11-22 2023-01-04 대한켐텍 주식회사 피부 미용 개선용 원료 조성물의 제조방법

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877805A (en) * 1985-07-26 1989-10-31 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
WO1998046615A1 (de) * 1997-04-11 1998-10-22 Targor Gmbh Metallocen-aminosäure- und peptid-komplexe
WO1999045941A1 (en) * 1998-03-13 1999-09-16 Mrs, Llc Peptide compositions and formulations and use of same
WO2000028996A1 (en) * 1998-11-19 2000-05-25 Mrs, Llc Cosmetic or dermatological use of 7-hydroxylated steroids alone and/or in combination with elastin derived peptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998047921A1 (en) * 1997-04-21 1998-10-29 Schering Corporation Mammalian cytokines; related reagents and methods
AU784203B2 (en) * 1999-10-29 2006-02-23 Glaxosmithkline Biologicals S.A. Neisserial antigenic peptides

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877805A (en) * 1985-07-26 1989-10-31 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
WO1998046615A1 (de) * 1997-04-11 1998-10-22 Targor Gmbh Metallocen-aminosäure- und peptid-komplexe
WO1999045941A1 (en) * 1998-03-13 1999-09-16 Mrs, Llc Peptide compositions and formulations and use of same
WO2000028996A1 (en) * 1998-11-19 2000-05-25 Mrs, Llc Cosmetic or dermatological use of 7-hydroxylated steroids alone and/or in combination with elastin derived peptides

Also Published As

Publication number Publication date
NZ523403A (en) 2005-04-29
WO2001091700A2 (en) 2001-12-06
AU2001275018B2 (en) 2008-04-03
NO20030454D0 (no) 2003-01-29
NO20030454L (no) 2003-01-29
IL153687A0 (en) 2003-07-06
CA2415225A1 (en) 2001-12-06
EP1392346A2 (en) 2004-03-03
WO2001091700A8 (en) 2003-11-20
AU7501801A (en) 2001-12-11

Similar Documents

Publication Publication Date Title
AU8657601A (en) Composition and method for treatment of hypertriglyceridemia
AU2002230831A1 (en) Compositions of human proteins and method of use thereof
IL213845A0 (en) Method and composition for treatment of skeletal dysplasias
AU1166502A (en) Human ect2 and methods of use
EP1157707B8 (en) Method and composition for deforming soft tissues
GB0014969D0 (en) Novel method of treatment
EP1438062A4 (en) METHOD AND COMPOSITIONS FOR TREATING SKIN Lions
GB0110288D0 (en) Composition and treatment method
AU6832101A (en) Composition and method
AU4163402A (en) Composition and method
IL153687A0 (en) Composition and method for enhancing elasticity of tissue
HK1047879A1 (zh) 改進的假肢及其裝配方法
AU7311501A (en) Cosmetic composition and method
HU0104832D0 (en) Cosmetic composition and method
AU2001234831A1 (en) Magnetoliposome composition for targeted treatment of biological tissue and associated methods
AU2003282593A8 (en) Polyphenolamine composition and method of use
EP1263935A4 (en) SCYTONEMINE AND METHODS OF USE
GB2399500B (en) Composition and method for treatment of wounds
GB0008921D0 (en) Method of treatment
IL151403A0 (en) Compositions and methods for treatment of epilepsy
GB0105472D0 (en) Smoke composition and method of use thereof
AU2001253469A1 (en) Compositions and methods for stabilizing modified tissue
EP1272512A4 (en) IMMUNOKIN COMPOSITION AND METHOD
EP1303281A4 (en) METHODS OF TREATMENT
GB0016437D0 (en) Method of and composition for tattooing

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20021227

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1063738

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20060925

17Q First examination report despatched

Effective date: 20070914

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20100621

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1063738

Country of ref document: HK